Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Tuberculosis Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Mycobacterium tuberculosis Medicine & Life Sciences
Rifampin Medicine & Life Sciences
Pyrazinamide Medicine & Life Sciences
rifapentine Medicine & Life Sciences
moxifloxacin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2017

Bactericidal and sterilizing activity of a novel regimen with bedaquiline, pretomanid, moxifloxacin, and pyrazinamide in a murine model of tuberculosis

Li, S. Y., Tasneen, R., Tyagi, S., Soni, H., Converse, P. J., Mdluli, K. & Nuermberger, E. L. Sep 1 2017 In : Antimicrobial Agents and Chemotherapy. 61, 9, e00913-17

Research output: Research - peer-reviewArticle

bedaquiline
Pyrazinamide
Tuberculosis
moxifloxacin
2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo(2,1-b)(1,3)oxazine

Drug resistance mechanisms and novel drug targets for tuberculosis therapy

Islam, M. M., Hameed, H. M. A., Mugweru, J., Chhotaray, C., Wang, C., Tan, Y., Liu, J., Li, X., Tan, S., Ojima, I., Yew, W. W., Nuermberger, E., Lamichhane, G. & Zhang, T. Jan 20 2017 In : Journal of Genetics and Genomics. 44, 1, p. 21-37 17 p.

Research output: Research - peer-reviewReview article

Drug Resistance
Tuberculosis
Pharmaceutical Preparations
Therapeutics
Multidrug-Resistant Tuberculosis

In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis

Kaushik, A., Ammerman, N. C., Tasneen, R., Story-Roller, E., Dooley, K. E., Dorman, S. E., Nuermberger, E. L. & Lamichhane, G. Aug 1 2017 In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2320-2325 6 p., dkx152

Research output: Research - peer-reviewArticle

biapenem
Rifampin
Mycobacterium tuberculosis
Pharmaceutical Preparations
In Vitro Techniques

In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1

Gopal, P., Tasneen, R., Yee, M., Lanoix, J. P., Sarathy, J., Rasic, G., Li, L., Dartois, V., Nuermberger, E. & Dick, T. Jul 14 2017 In : ACS Infectious Diseases. 3, 7, p. 492-501 10 p.

Research output: Research - peer-reviewArticle

aspartate 4-decarboxylase
Missense Mutation
Mycobacterium tuberculosis
pyrazinoic acid
Pyrazinamide

New Paradigm for Translational Modeling to Predict Long-term Tuberculosis Treatment Response

Bartelink, I. H., Zhang, N., Keizer, R. J., Strydom, N., Converse, P. J., Dooley, K. E., Nuermberger, E. L. & Savic, R. M. 2017 (Accepted/In press) In : Clinical and Translational Science.

Research output: Research - peer-reviewArticle

Tuberculosis
Confidence Intervals
Therapeutics
Rifampin
Pharmacokinetics